{"chat": [{"from": "Andrew", "title": "Hello", "to": "Andrew", "location": "Prince George", "date": "04-27-2023", "message": "This is a test message", "type": "message", "id": 1}, {"title": "COVID-19, Paxlovid", "to": "Everyone", "location": "UHNBC", "date": "17-07-2023", "message": "Paxlovid dosing for patients with eGFR>30 to <60ml/min:\n150 mg nirmatrelvir taken with ritonavir 100 mg Q12H for 5 days.\n\n\nPaxlovid is not recommended for patients with severe renal impairment (eGFR <30 ml/min).\n\n", "type": "Doctor", "by": "Abu Hamour"}, {"title": "Dosing Duplication", "to": "Everyone", "location": "", "date": "22-07-2023", "message": "For dosing eGFR 60 mL/min or greater the Paxlovid 150 mg/100 mg po BID x 5 days line should be removed.\u00a0", "type": "Pharmacist", "by": "Sumeet Hayer"}, {"title": "", "to": "Everyone", "location": "PRRH", "date": "22-07-2023", "message": "First entry has\u00a0\u00a0nirmatrelvir-ritonavir 150 mg-100 mg (300 mg-100 mg Dose) oral tablet but is this supposed to be 300 mg -100 mg for the first part before the brackets as well? <br> Agree there\u2019s a duplicate entry right below that. <br><br>There should be a note that there are multiple DDI with Paxlovid and alert the prescriber to discuss with pharmacy or use the following tool https://www.covid19-druginteractions.org/checker", "type": "Doctor", "by": "Salpy Kelian"}]}